Stay updated on Fazirsiran Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.

Latest updates to the Fazirsiran Safety & Efficacy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a related topic entry for Alpha-1-antitrypsin deficiency and a link to the Genetic and Rare Diseases Information Center as a resource.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved references to Alpha 1-antitrypsin deficiency and the Genetic and Rare Diseases Information Center resources.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.5.0 is now displayed on the page, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.4.2 was added and the previous notices about government funding and operating status (Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check69 days agoChange DetectedA site-wide notice about a lapse in government funding was added, informing users that transactions may not be processed and directing users to cc.nih.gov and opm.gov for updates. A new site revision (v3.4.1) was released, replacing the previous v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Fazirsiran Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.